Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Adult Humans Mycobacterium Infections, Nontuberculous / diagnosis Mycobacterium abscessus Mycobacterium avium Complex Mycobacterium kansasii Nontuberculous Mycobacteria

Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
07 2020
Historique:
received: 03 03 2020
accepted: 03 03 2020
entrez: 9 7 2020
pubmed: 9 7 2020
medline: 22 6 2021
Statut: epublish

Résumé

Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites. This guideline focuses on pulmonary disease in adults (without cystic fibrosis or human immunodeficiency virus infection) caused by the most common NTM pathogens such as

Identifiants

DOI: 10.1183/13993003.00535-2020 PMID: 32636299 PMC: PMC8375621
pubmed: 32636299
pii: 56/1/2000535
doi: 10.1183/13993003.00535-2020
pmc: PMC8375621
mid: NIHMS1726272
pii:
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Intramural NIH HHS
ID : Z99 HL999999
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA HL006200
Pays : United States

Informations de copyright

Copyright © The Author(s) 2020. This version published by the European Respiratory Society in the European Respiratory Journal, and jointly with Clinical Infectious Diseases. The articles are identical except for minor stylistic and spelling differences in keeping with each journal's style. Either citation can be used when citing this article.

Déclaration de conflit d'intérêts

Conflict of interest: C.L. Daley served on advisory committees for Cipla, Horizon, Insmed, Johnson & Johnson, Matinas Biopharma, Otsuka America Pharmaceutical, Paratek, and Spero; received research support from Beyond Air, Insmed, and Spero; served as a consultant for Meiji. Conflict of interest: J.M. Iaccarino has nothing to disclose. Conflict of interest: C. Lange served as a speaker for Berlin Chemie, Chiesi, Gilead, Janssen, Lucane, and Novartis; served on an advisory committee for Oxford Immunotec. Conflict of interest: E. Cambau has nothing to disclose. Conflict of interest: R.J. Wallace Jr served as the director of a university clinical laboratory that does NTM identification, molecular strain comparison, and susceptibility testing; received research support from Insmed as mycobacterial reference laboratory for a trial of the inhaled liposomal amikacin. Conflict of interest: C. Andrejak received research support from Insmed. Conflict of interest: E.C. Böttger served as a consultant for AID Diagnostika, Becton Dickinson, and COPAN; provided expert testimony for Shuttleworth & Ingersoll law firm. Conflict of interest: J. Brozek has nothing to disclose. Conflict of interest: D.E. Griffith served on an advisory committee, as a consultant, as a speaker and received research support from Insmed; served as a consultant for Johnson & Johnson, Merck, and Spero. Conflict of interest: L. Guglielmetti has nothing to disclose. Conflict of interest: G.A. Huitt served on an advisory committee for Hill-Rom and Insmed. Conflict of interest: S.L. Knight has nothing to disclose. Conflict of interest: P. Leitman served as the president of NTM Info & Research, Inc, during which time the organization received support from Insmed, Grifols, BeyondAir, Aradigm, Spero Therapeutics, Johnson & Johnson, Hill-Rom, International Biophysics, Electromed, RespirTech, Maxor Specialty Pharmacy, PantherX, and Kroger Specialty Pharmacy. Conflict of interest: T.K. Marras served as a consultant and received research support from Insmed; served as a speaker for AstraZeneca and Novartis; served as a consultant for Horizon, Spero, and RedHill Biopharma. Conflict of interest: K.N. Olivier received research support from AIT Therapeutics, Insmed, and Matinas Biopharma. Conflict of interest: M. Santin received personal fees from DiaSorin SPA and Vircell SL. Conflict of interest: J.E. Stout has nothing to disclose. Conflict of interest: E. Tortoli has nothing to disclose. Conflict of interest: J. van Ingen served on an advisory committee and as a consultant for Insmed; served on advisory committees for Janssen Pharmaceuticals and Spero. Conflict of interest: D. Wagner served as a speaker for Cepheid GmbH; received research support and travel expenses from Insmed. Conflict of interest: K.L. Winthrop served on an advisory committee for Insmed, Johnson and Johnson, Paratek, Redhill Biopharma, and Spero; served as a consultant for Bayer Healthcare, Bristol-Myers Squibb, Horizon, Lilly, Pfizer, and RedHill Biopharma; received research support from Bristol-Myers Squibb, Cellestis, and Insmed; served on data safety and monitoring boards for Abbvie, Biomarin, Gilead, Roche, and UCB.

Références

Thorax. 1994 May;49(5):442-5
pubmed: 8016763
Chest. 2006 Mar;129(3):771-6
pubmed: 16537880
Tubercle. 1988 Jun;69(2):139-43
pubmed: 3055575
J Clin Microbiol. 2000 Jan;38(1):398-401
pubmed: 10618124
Thorax. 2001 Mar;56(3):167-72
pubmed: 11182006
Antimicrob Agents Chemother. 2016 Sep 23;60(10):6076-83
pubmed: 27480854
J Korean Med Sci. 2008 Jun;23(3):397-401
pubmed: 18583873
Thorax. 2009 Jun;64(6):502-6
pubmed: 19213773
Emerg Infect Dis. 2016 Mar;22(3):511-4
pubmed: 26890211
Antimicrob Agents Chemother. 2018 Mar 27;62(4):
pubmed: 29437627
Antimicrob Agents Chemother. 2015 Apr;59(4):2273-9
pubmed: 25645830
Cardiology. 2008;111(4):280-7
pubmed: 18451646
Clin Infect Dis. 2000 Feb;30(2):288-92
pubmed: 10671330
Int J Tuberc Lung Dis. 2016 Jul;20(7):934-40
pubmed: 27287647
Int J Tuberc Lung Dis. 2009 Dec;13(12):1572-5
pubmed: 19919781
J Clin Epidemiol. 2011 Apr;64(4):395-400
pubmed: 21194891
J Clin Microbiol. 1998 Jan;36(1):139-47
pubmed: 9431937
Kurume Med J. 2001;48(1):15-9
pubmed: 11402614
J Clin Microbiol. 2012 Nov;50(11):3556-61
pubmed: 22915613
J Infect. 2009 Nov;59(5):324-31
pubmed: 19732795
Respir Med. 2015 Jan;109(1):137-45
pubmed: 25464905
J Antimicrob Chemother. 2016 Aug;71(8):2208-12
pubmed: 27147307
Antimicrob Agents Chemother. 2004 Dec;48(12):4562-5
pubmed: 15561826
Antimicrob Agents Chemother. 2001 Nov;45(11):3229-30
pubmed: 11600387
Am J Respir Crit Care Med. 2011 Feb 1;183(3):405-10
pubmed: 20833823
Antimicrob Agents Chemother. 2015 Aug;59(8):4994-6
pubmed: 25987622
Pharmacotherapy. 2008 Aug;28(8):1076-80
pubmed: 18657024
J Clin Microbiol. 2016 Jul;54(7):1915-1917
pubmed: 27147723
N Engl J Med. 1996 Aug 8;335(6):384-91
pubmed: 8663871
Am J Respir Crit Care Med. 2012 Nov 1;186(9):917-25
pubmed: 22878281
Chest. 2017 Jul;152(1):120-142
pubmed: 28461147
Ann Thorac Surg. 2001 Dec;72(6):1877-82
pubmed: 11789763
J Microbiol Immunol Infect. 2015 Aug;48(4):437-45
pubmed: 25440976
Kansenshogaku Zasshi. 1999 Aug;73(8):728-33
pubmed: 10487017
Tuber Lung Dis. 1995 Apr;76(2):104-8
pubmed: 7780090
Am J Respir Crit Care Med. 1994 May;149(5):1335-41
pubmed: 8173775
Eur J Clin Microbiol Infect Dis. 2000 May;19(5):350-4
pubmed: 10898135
Int J Tuberc Lung Dis. 2012;16(3):408-14
pubmed: 22230733
J Antimicrob Chemother. 2005 Jun;55(6):950-3
pubmed: 15824090
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6758-6765
pubmed: 27572413
Int J Tuberc Lung Dis. 2012 May;16(5):660-4
pubmed: 22410245
Chest. 2017 May;151(5):982-992
pubmed: 27889361
Clin Infect Dis. 1997 May;24(5):958-64
pubmed: 9142801
Respir Med. 2011 Nov;105(11):1718-25
pubmed: 21868209
Clin Microbiol Rev. 2012 Jul;25(3):545-82
pubmed: 22763637
Int J Tuberc Lung Dis. 2010 Sep;14(9):1176-80
pubmed: 20819265
Thorax. 1984 May;39(5):376-82
pubmed: 6740540
J Cyst Fibros. 2015 Jan;14(1):63-9
pubmed: 25085077
J Clin Microbiol. 2010 Jan;48(1):307-10
pubmed: 19906898
Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 2):S1-25
pubmed: 9279284
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416
pubmed: 17277290
Lung. 2011 Dec;189(6):467-74
pubmed: 21956280
Clin Microbiol Infect. 2018 Jun;24(6):599-603
pubmed: 29174730
Int J Antimicrob Agents. 2013 Sep;42(3):256-61
pubmed: 23837923
Ann Intern Med. 1994 Dec 15;121(12):905-11
pubmed: 7978715
Am J Clin Pathol. 1953 Apr;23(4):363-74
pubmed: 13040295
Ann Am Thorac Soc. 2014 Jan;11(1):23-9
pubmed: 24298907
Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):564-9
pubmed: 1832527
Am J Respir Crit Care Med. 2012 Sep 15;186(6):559-65
pubmed: 22744719
Chest. 2016 May;149(5):1285-93
pubmed: 26513209
Emerg Infect Dis. 2008 Mar;14(3):385-9
pubmed: 18325251
Chest. 1999 Apr;115(4):1033-40
pubmed: 10208205
Clin Chest Med. 2015 Mar;36(1):13-34
pubmed: 25676516
J Clin Microbiol. 2003 Dec;41(12):5699-708
pubmed: 14662964
Clin Infect Dis. 2017 Oct 1;65(7):1077-1084
pubmed: 28582488
J Microbiol Biotechnol. 2009 Oct;19(10):1259-64
pubmed: 19884789
Clin Infect Dis. 1995 Sep;21(3):594-8
pubmed: 8527549
Ann Am Thorac Soc. 2016 Jan;13(1):40-8
pubmed: 26540302
J Med Microbiol. 1998 Sep;47(9):821-7
pubmed: 9736164
Int J Clin Pharmacol Ther. 1996 Sep;34(9):400-5
pubmed: 8880291
Antimicrob Agents Chemother. 2009 Apr;53(4):1367-76
pubmed: 19171799
Am J Respir Crit Care Med. 2012 Apr 15;185(8):881-6
pubmed: 22312016
Chest. 2003 Oct;124(4):1482-6
pubmed: 14555583
Respir Med. 2011 May;105(5):781-7
pubmed: 21211956
Drug Resist Updat. 2012 Jun;15(3):149-61
pubmed: 22525524
Rev Infect Dis. 1981 Sep-Oct;3(5):1035-9
pubmed: 7339801
BMC Infect Dis. 2017 Aug 9;17(1):558
pubmed: 28793869
EBioMedicine. 2016 Jul;9:228-237
pubmed: 27333026
Ann Thorac Surg. 1998 Aug;66(2):325-30
pubmed: 9725364
Diagn Microbiol Infect Dis. 2013 Feb;75(2):225-6
pubmed: 23140755
Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1766-72
pubmed: 8665032
Antimicrob Agents Chemother. 2018 Jun 26;62(7):
pubmed: 29661870
Respir Med. 2016 Nov;120:101-108
pubmed: 27817806
J Antimicrob Chemother. 2017 Sep 1;72(suppl_2):i3-i19
pubmed: 28922813
J Med Microbiol. 2012 Sep;61(Pt 9):1234-1239
pubmed: 22700551
Antimicrob Agents Chemother. 2015 Dec 07;60(2):1097-105
pubmed: 26643335
Cochrane Database Syst Rev. 2019 Jan 18;1:CD011825
pubmed: 30656650
Respirology. 2014 Jul;19(5):714-22
pubmed: 24690015
J Infect. 2007 Jul;55(1):34-40
pubmed: 17360040
Antimicrob Agents Chemother. 2011 Feb;55(2):775-81
pubmed: 21135185
Am J Respir Crit Care Med. 2015 Jan 1;191(1):96-103
pubmed: 25393520
Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559-1569
pubmed: 30216086
J Infect Chemother. 2006 Aug;12(4):195-202
pubmed: 16944258
Am J Respir Crit Care Med. 2010 Oct 1;182(7):970-6
pubmed: 20538958
Clin Microbiol Infect. 2015 Mar;21(3):250.e1-7
pubmed: 25658545
Am J Respir Crit Care Med. 2017 Mar 15;195(6):814-823
pubmed: 27748623
Ann Am Thorac Soc. 2014 Jan;11(1):96-7
pubmed: 24460440
J Clin Microbiol. 2009 Jul;47(7):1985-95
pubmed: 19420162
Cochrane Database Syst Rev. 2018 Mar 15;3:CD012406
pubmed: 29543980
BMC Infect Dis. 2015 Feb 19;15:76
pubmed: 25887191
Chang Gung Med J. 2009 Sep-Oct;32(5):499-508
pubmed: 19840507
Ann Thorac Surg. 2008 Jun;85(6):1887-92; discussion 1892-3
pubmed: 18498789
Ann Am Thorac Soc. 2014 Jan;11(1):30-5
pubmed: 24460437
Clin Infect Dis. 1999 May;28(5):1080-5
pubmed: 10452638
Respir Med. 2014 Nov;108(11):1706-12
pubmed: 25245792
Int J Syst Evol Microbiol. 2016 Nov;66(11):4471-4479
pubmed: 27499141
Medicine (Baltimore). 2019 Apr;98(17):e15285
pubmed: 31027086
Eur Respir J. 2017 Sep 27;50(3):
pubmed: 28954780
Chest. 1988 Mar;93(3):550-5
pubmed: 3342664
J Infect Chemother. 2003 Dec;9(4):328-32
pubmed: 14691654
Chest. 2018 Apr;153(4):888-921
pubmed: 29410162
Qual Life Res. 2014 Dec;23(10):2735-41
pubmed: 24908057
Int J Tuberc Lung Dis. 2010 Jan;14(1):99-105
pubmed: 20003702
Clin Infect Dis. 2016 Oct 1;63(7):e147-e195
pubmed: 27516382
Int J Antimicrob Agents. 2001;18 Suppl 1:S71-6
pubmed: 11574199
Am J Respir Crit Care Med. 2015 Sep 15;192(6):754-60
pubmed: 26068042
Ann Am Thorac Soc. 2016 Sep;13(9):S379-84
pubmed: 27627485
Antimicrob Agents Chemother. 2016 Dec 27;61(1):
pubmed: 27799212
Respir Med. 2007 Jan;101(1):130-8
pubmed: 16750618
Int J Tuberc Lung Dis. 2009 Oct;13(10):1210-8
pubmed: 19793424
BMC Infect Dis. 2016 Aug 09;16:396
pubmed: 27506679
Thorax. 1983 May;38(5):373-7
pubmed: 6879487
Ann Am Thorac Soc. 2016 Nov;13(11):1904-1911
pubmed: 27513168
Respir Med. 2003 Apr;97(4):439-44
pubmed: 12693807
Ann Thorac Surg. 2004 Aug;78(2):399-403
pubmed: 15276484
Eur J Cardiothorac Surg. 2002 Feb;21(2):314-8
pubmed: 11825742
J Infect Dis. 1998 Jul;178(1):121-6
pubmed: 9652431
BMC Pulm Med. 2007 Feb 23;7:2
pubmed: 17319962
Am Rev Respir Dis. 1993 May;147(5):1271-8
pubmed: 8484642
Expert Opin Pharmacother. 2009 Feb;10(3):381-401
pubmed: 19191677
J Clin Microbiol. 2006 Nov;44(11):4014-7
pubmed: 17005737
Emerg Infect Dis. 2017 Mar;23(3):468-476
pubmed: 28221106
N Engl J Med. 1996 Aug 8;335(6):377-83
pubmed: 8676931
J Clin Microbiol. 2004 Jul;42(7):3000-11
pubmed: 15243051
Int J Med Microbiol. 2013 Jul;303(5):270-6
pubmed: 23689069
J Antimicrob Chemother. 2012 Nov;67(11):2606-11
pubmed: 22833642
Thorax. 2009 Apr;64(4):291-6
pubmed: 19052044
Thorax. 2008 Jul;63(7):627-34
pubmed: 18250184
J Clin Microbiol. 2014 Jul;52(7):2544-51
pubmed: 24808238
J Infect. 2009 Feb;58(2):108-12
pubmed: 19195711
Antimicrob Agents Chemother. 1992 Sep;36(9):1987-90
pubmed: 1416891
Chest. 2004 Aug;126(2):566-81
pubmed: 15302746
Ann Thorac Surg. 1998 Jul;66(1):183-6
pubmed: 9692461
J Clin Microbiol. 2011 Jul;49(7):2691-3
pubmed: 21543566
Antimicrob Agents Chemother. 2017 Jan 24;61(2):
pubmed: 27872066
Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1883-7
pubmed: 22198679
Clin Infect Dis. 2017 Feb 1;64(3):301-308
pubmed: 28011609
Ann Am Thorac Soc. 2013 Aug;10(4):299-306
pubmed: 23952847
Am J Respir Crit Care Med. 2006 Jun 1;173(11):1283-9
pubmed: 16514112
Respirology. 2016 Feb;21(2):357-62
pubmed: 26581837
Int J Tuberc Lung Dis. 2003 Jun;7(6):569-74
pubmed: 12797700
J Microbiol Immunol Infect. 2010 Oct;43(5):401-6
pubmed: 21075707
Ann Am Thorac Soc. 2015 May;12(5):642-7
pubmed: 25692495
Clin Infect Dis. 2003 Nov 1;37(9):1178-82
pubmed: 14557961
Eur Respir J. 2017 Mar 8;49(3):
pubmed: 28275170
Clin Infect Dis. 2004 Jun 1;38(11):1538-44
pubmed: 15156439
Clin Chest Med. 2015 Mar;36(1):79-90
pubmed: 25676521
Am J Respir Crit Care Med. 2010 Mar 1;181(5):514-21
pubmed: 20007929
J Infect Chemother. 2017 May;23(5):293-300
pubmed: 28254517
Antimicrob Agents Chemother. 2012 Dec;56(12):6324-7
pubmed: 23027189
J Clin Microbiol. 2010 Nov;48(11):3943-8
pubmed: 20826640
J Clin Microbiol. 2011 Feb;49(2):491-9
pubmed: 21106786
J Infect Dis. 1998 Jun;177(6):1573-81
pubmed: 9607835
Int J Antimicrob Agents. 2013 Jul;42(1):80-2
pubmed: 23664674
Eur Respir J. 2009 Jan;33(1):148-52
pubmed: 19118226
Antimicrob Agents Chemother. 1996 Jul;40(7):1676-81
pubmed: 8807061
J Clin Microbiol. 2013 Oct;51(10):3389-94
pubmed: 23946523
J Infect Dis. 1996 Aug;174(2):354-60
pubmed: 8699066
J Clin Epidemiol. 2013 Jul;66(7):726-35
pubmed: 23570745
Diagn Microbiol Infect Dis. 1993 Mar-Apr;16(3):215-21
pubmed: 8477575
J Infect Chemother. 2012 Apr;18(2):146-51
pubmed: 21927844
Infect Genet Evol. 2012 Jun;12(4):832-7
pubmed: 22036704
J Infect Dis. 2002 Jul 15;186(2):266-73
pubmed: 12134265
J Infect Dis. 1996 Mar;173(3):677-83
pubmed: 8627032
Am J Respir Crit Care Med. 1999 Sep;160(3):866-72
pubmed: 10471610
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28807911
Chest. 2015 May;147(5):1369-1375
pubmed: 25357074
Am Rev Respir Dis. 1975 Jul;112(1):31-6
pubmed: 1147382
Am J Respir Crit Care Med. 2012 Mar 1;185(5):575-83
pubmed: 22199005
Ann Intern Med. 1990 Mar 15;112(6):407-15
pubmed: 2106816
Chest. 2014 Aug;146(2):276-282
pubmed: 24457542
Am Rev Respir Dis. 1987 Jan;135(1):10-6
pubmed: 3800137
Am J Respir Crit Care Med. 2006 Oct 15;174(8):928-34
pubmed: 16858014
N Engl J Med. 1996 Aug 8;335(6):392-8
pubmed: 8676932
Am J Respir Crit Care Med. 2005 Jul 15;172(2):250-3
pubmed: 15860751
Ann Thorac Surg. 2006 Jun;81(6):2026-30
pubmed: 16731124
Eur J Cardiothorac Surg. 2011 Sep;40(3):671-5
pubmed: 21324708
Antimicrob Agents Chemother. 1994 Feb;38(2):381-4
pubmed: 8192472
Thorax. 1981 May;36(5):326-9
pubmed: 7313999
J Infect Chemother. 2012 Aug;18(4):436-43
pubmed: 22205543
J Clin Microbiol. 2004 May;42(5):2321-5
pubmed: 15131224
Eur Respir J. 2018 Mar 22;51(3):
pubmed: 29567726
Clin Infect Dis. 1996 Nov;23(5):983-9
pubmed: 8922790
Am J Clin Pathol. 2014 Jan;141(1):25-34
pubmed: 24343734
Am J Respir Crit Care Med. 2012 Oct 15;186(8):797-802
pubmed: 22878282
Am Rev Respir Dis. 1983 Dec;128(6):1048-50
pubmed: 6650978
Antimicrob Agents Chemother. 2018 Jan 25;62(2):
pubmed: 29203483
Int J Tuberc Lung Dis. 1997 Oct;1(5):454-9
pubmed: 9441101
Clin Infect Dis. 1994 May;18(5):736-43
pubmed: 8075262
Emerg Infect Dis. 2013 Nov;19(11):1889-91
pubmed: 24210012
Am J Respir Crit Care Med. 1997 Jun;155(6):2041-6
pubmed: 9196113
Clin Infect Dis. 2011 Mar 1;52(5):565-71
pubmed: 21292659
Clin Infect Dis. 2003 Nov 1;37(9):1234-43
pubmed: 14557969
Int J Syst Evol Microbiol. 2018 Nov;68(11):3666-3677
pubmed: 30231956
BMJ Open. 2015 Aug 05;5(8):e008058
pubmed: 26246077
Chest. 2016 Dec;150(6):1211-1221
pubmed: 27167209
J Antimicrob Chemother. 2015 Oct;70(10):2838-43
pubmed: 26142475
Am J Respir Crit Care Med. 2009 Nov 1;180(9):896-902
pubmed: 19661243
Clin Infect Dis. 2001 Jun 1;32(11):1547-53
pubmed: 11340525
Am J Clin Pathol. 2002 Oct;118(4):542-5
pubmed: 12375641
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
Rev Infect Dis. 1981 Sep-Oct;3(5):1028-34
pubmed: 7339800
J Clin Microbiol. 2017 Jul;55(7):2045-2054
pubmed: 28424252
Chest. 1991 Mar;99(3):667-9
pubmed: 1995223
Am J Respir Crit Care Med. 2006 Sep 1;174(5):605-14
pubmed: 16931644
Can Assoc Radiol J. 2014 Aug;65(3):207-13
pubmed: 24325924
Respir Med. 2017 Oct;131:220-224
pubmed: 28947034
Clin Microbiol Infect. 2010 Sep;16(9):1470-4
pubmed: 19930269
Clin Infect Dis. 2017 Feb 1;64(3):309-316
pubmed: 28011608
J Antimicrob Chemother. 2013 Mar;68(3):659-65
pubmed: 23129730
BMJ. 2013 Mar 20;346:f1235
pubmed: 23525864

Auteurs

Charles L Daley (CL)

Dept of Medicine, National Jewish Health, Denver, CO, USA.
Dept of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
C.L. Daley, C. Lange, E. Cambau and R.J. Wallace Jr are cochairs of this guideline committee.

Jonathan M Iaccarino (JM)

Pulmonary Center, Boston University School of Medicine, Boston, MA, USA.

Christoph Lange (C)

Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
German Center for Infection Research (DZIF), Clinical Tuberculosis Unit, Borstel, Germany.
Respiratory Medicine and International Health, University of Lübeck, Lübeck, Germany.
Dept of Medicine, Karolinska Institute, Stockholm, Sweden.
C.L. Daley, C. Lange, E. Cambau and R.J. Wallace Jr are cochairs of this guideline committee.

Emmanuelle Cambau (E)

National Reference Center for Mycobacteria and Antimycobacterial Resistance, APHP -Hôpital Lariboisière, Bacteriology; Inserm, University Paris Diderot, IAME UMR1137, Paris, France.
C.L. Daley, C. Lange, E. Cambau and R.J. Wallace Jr are cochairs of this guideline committee.

Richard J Wallace (RJ)

Mycobacteria/Nocardia Laboratory, Dept of Microbiology, The University of Texas Health Science Center, Tyler, TX, USA.
C.L. Daley, C. Lange, E. Cambau and R.J. Wallace Jr are cochairs of this guideline committee.

Claire Andrejak (C)

Respiratory and Intensive Care Unit, University Hospital Amiens, Amiens, France.
EA 4294, AGIR, Jules Verne Picardy University, Amiens, France.

Erik C Böttger (EC)

Institute of Medical Microbiology, National Reference Center for Mycobacteria, University of Zurich, Zurich, Switzerland.

Jan Brozek (J)

Dept of Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Centre, Hamilton, ON, Canada.
ORCID: 0000-0002-3122-0773

David E Griffith (DE)

Pulmonary Infectious Disease Section, University of Texas Health Science Center, Tyler, TX, USA.

Lorenzo Guglielmetti (L)

National Reference Center for Mycobacteria and Antimycobacterial Resistance, APHP -Hôpital Lariboisière, Bacteriology; Inserm, University Paris Diderot, IAME UMR1137, Paris, France.
Team E13 (Bactériologie), Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Université Pierre et Marie Curie, Université Paris 06, Centre de Recherche 7, INSERM, IAME UMR1137, Paris, France.
ORCID: 0000-0003-0886-9635

Gwen A Huitt (GA)

Dept of Medicine, National Jewish Health, Denver, CO, USA.
Dept of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
ORCID: 0000-0003-0398-8109

Shandra L Knight (SL)

Library and Knowledge Services, National Jewish Health, Denver, CO, USA.

Philip Leitman (P)

NTM Info and Research, Miami, FL, USA.

Theodore K Marras (TK)

Dept of Medicine, University of Toronto and University Health Network, Toronto, ON, Canada.

Kenneth N Olivier (KN)

Pulmonary Branch, National Heart, Lung and Blood Institute, Bethesda, MD, USA.
ORCID: 0000-0001-8200-255X

Miguel Santin (M)

Service of Infectious Diseases, Bellvitge University Hospital-IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
ORCID: 0000-0002-8474-3543

Jason E Stout (JE)

Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC, USA.
ORCID: 0000-0002-6698-8176

Enrico Tortoli (E)

Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
ORCID: 0000-0001-5512-704X

Jakko van Ingen (J)

Radboud Center for Infectious Diseases, Dept of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
ORCID: 0000-0002-0581-2003

Dirk Wagner (D)

Division of Infectious Diseases, Dept of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
ORCID: 0000-0002-3271-5815

Kevin L Winthrop (KL)

Divisions of Infectious Diseases, Schools of Public Health and Medicine, Oregon Health and Science University, Portland, OR, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Treatment of nontuberculous mycobacterial...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Treatment of nontuberculous mycobacterial...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Infections à Actinomycetales › Infections à Mycobacterium › Infections à mycobactéries non tuberculeuses › Treatment of nontuberculous mycobacterial...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets asporogènes à Gram positif › Bâtonnets asporogènes réguliers à Gram positif › Mycobacteriaceae › Mycobacterium › Mycobactéries non tuberculeuses › Mycobacterium abscessus › Treatment of nontuberculous mycobacterial...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets asporogènes à Gram positif › Bâtonnets asporogènes réguliers à Gram positif › Mycobacteriaceae › Mycobacterium › Mycobactéries non tuberculeuses › Complexe Mycobacterium avium › Treatment of nontuberculous mycobacterial...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets asporogènes à Gram positif › Bâtonnets asporogènes réguliers à Gram positif › Mycobacteriaceae › Mycobacterium › Mycobactéries non tuberculeuses › Mycobacterium kansasii › Treatment of nontuberculous mycobacterial...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets asporogènes à Gram positif › Bâtonnets asporogènes réguliers à Gram positif › Mycobacteriaceae › Mycobacterium › Mycobactéries non tuberculeuses › Treatment of nontuberculous mycobacterial...